b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">31689948</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>01</Month>\n            <Day>08</Day>\n        </DateRevised>\n        <Article PubModel="Electronic">\n            <Journal>\n                <ISSN IssnType="Print">2077-0383</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>8</Volume>\n                    <Issue>11</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Nov</Month>\n                        <Day>04</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of clinical medicine</Title>\n                <ISOAbbreviation>J Clin Med</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Involution of Breast Lobules, Mammographic Breast Density and Prognosis Among Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer Patients.</ArticleTitle>\n            <ELocationID EIdType="pii" ValidYN="Y">E1868</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm8111868</ELocationID>\n            <Abstract>\n                <AbstractText>Mammographic breast density (MD) reflects breast fibroglandular content. Its decline following adjuvant tamoxifen treated, estrogen receptor (ER)-positive breast cancer has been associated with improved outcomes. Breast cancers arise from structures termed lobules, and lower MD is associated with increased age-related lobule involution. We assessed whether pre-treatment involution influenced associations between MD decline and risk of breast cancer-specific death. ER-positive tamoxifen treated patients diagnosed at Kaiser Permanente Northwest (1990-2008) were defined as cases who died of breast cancer (<i>n</i> = 54) and matched controls (remained alive over similar follow-up; <i>n</i> = 180). Lobule involution was assessed by examining terminal duct lobular units (TDLUs) in benign tissues surrounding cancers as TDLU count/mm<sup>2</sup>, median span and acini count/TDLU. MD (%) was measured in the unaffected breast at baseline (median 6-months before) and follow-up (median 12-months after tamoxifen initiation). TDLU measures and baseline MD were positively associated among controls (<i>p</i> &lt; 0.05). In multivariable regression models, MD decline (\xe2\x89\xa510%) was associated with reduced risk of breast cancer-specific death before (odds ratio (OR): 0.41, 95% CI: 0.18-0.92) and after (OR: 0.41, 95% CI: 0.18-0.94) adjustment for TDLU count/mm<sup>2</sup>, TDLU span (OR: 0.34, 95% CI: 0.14-0.84), and acini count/TDLU (OR: 0.33, 95% CI: 0.13-0.81). MD decline following adjuvant tamoxifen is associated with reduced risk of breast cancer-specific death, irrespective of pre-treatment lobule involution.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Mullooly</LastName>\n                    <ForeName>Maeve</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Population Health Sciences, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland. maevemullooly@rcsi.ie.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. maevemullooly@rcsi.ie.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Nyante</LastName>\n                    <ForeName>Sarah J</ForeName>\n                    <Initials>SJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiology and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. sarah_nyante@med.unc.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pfeiffer</LastName>\n                    <ForeName>Ruth M</ForeName>\n                    <Initials>RM</Initials>\n                    <Identifier Source="ORCID">0000-0001-7791-2698</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. pfeiffer@mail.nih.gov.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cora</LastName>\n                    <ForeName>Renata</ForeName>\n                    <Initials>R</Initials>\n                    <Identifier Source="ORCID">0000-0001-5103-1278</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Independent Contractor, CT(ASCP), MB(ASCP), Stamford, CT 06901, USA. renata.cora@nih.gov.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Butcher</LastName>\n                    <ForeName>Donna</ForeName>\n                    <Initials>D</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pathology-Histotechnology Laboratory, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, MD 21702, USA. butcherdo@mail.nih.gov.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sternberg</LastName>\n                    <ForeName>Lawrence</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pathology-Histotechnology Laboratory, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, MD 21702, USA. sternberglr@mail.nih.gov.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Aiello Bowles</LastName>\n                    <ForeName>Erin J</ForeName>\n                    <Initials>EJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Kaiser Permanente Washington Health Research Institute, Seattle, WA 98101, USA. Erin.A.Bowles@kp.org.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Fan</LastName>\n                    <ForeName>Shaoqi</ForeName>\n                    <Initials>S</Initials>\n                    <Identifier Source="ORCID">0000-0001-5894-7510</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. shaoqi.fan@nih.gov.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Figueroa</LastName>\n                    <ForeName>Jonine D</ForeName>\n                    <Initials>JD</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Usher Institute of Population Health Sciences and Informatics, CRUK Edinburgh Centre, Medical School, The University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, UK. jonine.figueroa@ed.ac.uk.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Weinmann</LastName>\n                    <ForeName>Sheila</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Kaiser Permanente Northwest Center for Health Research, Portland, OR 97227, USA. Sheila.Weinmann@kpchr.org.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hoover</LastName>\n                    <ForeName>Robert N</ForeName>\n                    <Initials>RN</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. hooverr@exchange.nih.gov.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Brinton</LastName>\n                    <ForeName>Louise A</ForeName>\n                    <Initials>LA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. brintonl@exchange.nih.gov.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Berrington de Gonzalez</LastName>\n                    <ForeName>Amy</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. berringtona@mail.nih.gov.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Glass</LastName>\n                    <ForeName>Andrew</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Kaiser Permanente Northwest Center for Health Research, Portland, OR 97227, USA. andy_5241@msn.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sherman</LastName>\n                    <ForeName>Mark E</ForeName>\n                    <Initials>ME</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Mayo Clinic, Jacksonville, FL 32224, USA. Sherman.Mark@mayo.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gierach</LastName>\n                    <ForeName>Gretchen L</ForeName>\n                    <Initials>GL</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. gierachg@mail.nih.gov.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>NCI-funded contracts HHSN261200-900017C and HHSN261201-200304P</GrantID>\n                    <Agency>Intramural Research Program of the National Cancer Institute at the National Institutes of Health</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>CPFPR-2013-1</GrantID>\n                    <Agency>Health Research Board in Ireland</Agency>\n                    <Country/>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>04</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Switzerland</Country>\n            <MedlineTA>J Clin Med</MedlineTA>\n            <NlmUniqueID>101606588</NlmUniqueID>\n            <ISSNLinking>2077-0383</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">breast cancer</Keyword>\n            <Keyword MajorTopicYN="N">involution</Keyword>\n            <Keyword MajorTopicYN="N">mammographic breast density</Keyword>\n            <Keyword MajorTopicYN="N">terminal duct lobular unit</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>09</Month>\n                <Day>30</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>17</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>22</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31689948</ArticleId>\n            <ArticleId IdType="pii">jcm8111868</ArticleId>\n            <ArticleId IdType="doi">10.3390/jcm8111868</ArticleId>\n            <ArticleId IdType="pmc">PMC6912285</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>J Clin Oncol. 2013 Jun 20;31(18):2249-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23610119</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Perm J. 2015 Spring;19(2):48-79</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25902343</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JNCI Cancer Spectr. 2018 Nov;2(4):pky072</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30746510</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Natl Cancer Inst. 2011 May 4;103(9):744-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21483019</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer. 2016 Feb 1;122(3):378-85</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26512815</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2019 Jul 1;145(1):70-77</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30561789</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Breast Cancer Res Treat. 2016 Feb;155(3):423-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26846985</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Prev Res (Phila). 2016 Feb;9(2):149-58</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26645278</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Natl Cancer Inst. 2015 Jun 10;107(9):null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26063794</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Natl Cancer Inst. 2006 Nov 15;98(22):1600-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17105983</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Breast Cancer Res Treat. 2016 Aug;159(1):163-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27488681</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Natl Cancer Inst. 2015 Feb 06;107(3):null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25663687</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2010 May 1;28(13):2207-12</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20351335</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer. 2009 Apr 1;115(7):1404-11</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19170235</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2009 Dec 10;27(35):5893-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19805686</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Breast Cancer Res. 2012 Apr 18;14(2):R64</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22513288</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Breast Cancer Res Treat. 2014 Nov;148(2):303-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25332094</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Breast Cancer Res. 2016 Dec 15;18(1):128</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27978856</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2016 Jun 20;34(18):2093-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27022110</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Annu Rev Med. 2011;62:233-47</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20887199</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Proc SPIE Int Soc Opt Eng. 2013 Mar 29;8676:</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25722829</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Natl Cancer Inst. 2014 Oct 01;106(10):null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25274491</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3:220-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26455641</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1159-69</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16775176</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2005 Jul 21;353(3):229-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16034008</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Cancer. 2008 Nov 4;99(9):1369-74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18781174</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Breast Cancer Res. 2017 May 25;19(1):61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28545469</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):930-937</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28148596</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biol Proced Online. 2011 Jun 10;13(1):4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21663682</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Maturitas. 2004 Sep 24;49(1):2-15</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15351091</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Breast Cancer Res Treat. 2014 Apr;144(3):479-502</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24615497</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Phys Med Biol. 1994 Oct;39(10):1629-38</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15551535</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'